Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wason

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Journal of Biopharmaceutical Statistics|June 2, 2012
Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomesJames M S Wason, Adrian P Mander
The Journal of Pediatrics|March 1, 1983
Acute pediatric theophylline overdose: a summary of 28 casesP Gaudreault, S Wason, F H Lovejoy
Journal of Statistical Planning and Inference|September 5, 2020
Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a thresholdChien-Ju Lin, James M S Wason
Pharmaceutical Statistics|August 14, 2020
Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rateJames M S Wason, David S Robertson
Annals of Emergency Medicine|February 1, 1990
Mnemonic [corrected] for diagnosis of acute mental status changeJ R Roberts, S Wason, E Siegel
Biometrics|March 7, 2022
Bayesian sample size determination using commensurate priors to leverage preexperimental dataHaiyan Zheng, Thomas Jaki, James M S Wason
Statistics in Medicine|March 27, 2013
Planning multi-arm screening studies within the context of a drug development programJames M S Wason, Thomas Jaki, Nigel Stallard
JAMA|September 4, 1981
Single high-dose pyridoxine treatment for isoniazid overdoseS Wason, P G Lacouture, F H Lovejoy
Biometrics|March 25, 2024
Bayesian sample size determination using commensurate priors to leverage pre-experimental dataHaiyan Zheng, Thomas Jaki, James M S Wason
BMC Medicine|August 3, 2019
When to keep it simple - adaptive designs are not always usefulJames M S Wason, Peter Brocklehurst, Christina Yap
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Journal of Biopharmaceutical Statistics|June 2, 2012
Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomesJames M S Wason, Adrian P Mander
The Journal of Pediatrics|March 1, 1983
Acute pediatric theophylline overdose: a summary of 28 casesP Gaudreault, S Wason, F H Lovejoy
Journal of Statistical Planning and Inference|September 5, 2020
Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a thresholdChien-Ju Lin, James M S Wason
Pharmaceutical Statistics|August 14, 2020
Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rateJames M S Wason, David S Robertson
Annals of Emergency Medicine|February 1, 1990
Mnemonic [corrected] for diagnosis of acute mental status changeJ R Roberts, S Wason, E Siegel
Biometrics|March 7, 2022
Bayesian sample size determination using commensurate priors to leverage preexperimental dataHaiyan Zheng, Thomas Jaki, James M S Wason
Statistics in Medicine|March 27, 2013
Planning multi-arm screening studies within the context of a drug development programJames M S Wason, Thomas Jaki, Nigel Stallard
JAMA|September 4, 1981
Single high-dose pyridoxine treatment for isoniazid overdoseS Wason, P G Lacouture, F H Lovejoy
Biometrics|March 25, 2024
Bayesian sample size determination using commensurate priors to leverage pre-experimental dataHaiyan Zheng, Thomas Jaki, James M S Wason
BMC Medicine|August 3, 2019
When to keep it simple - adaptive designs are not always usefulJames M S Wason, Peter Brocklehurst, Christina Yap
Pageof 14